AstraZeneca hit by lung cancer drug setback: Pharma giant halts trials of experimental Volrustomig treatment
Astra said its Volrustomig treatment, when combined with chemotherapy, was unlikely to help lung cancer patients live longer than rival offerings.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.dailymail.co.uk — the content belongs to Daily Mail Money.
